Vomiting was reported significantly less often in the Cotrifazid group than in the mefloquine group (p < 0.001);
Cotrifazid
standard treatment of quinine with sulfadoxine–pyrimethamine (SP)
stomach ache , vomiting, dizziness, and tinnitus